affiliate

CD8+ T cell immunity to viral pathogens (e.g., HIV, SARS-CoV2) and vaccination at various stages of human development.

Dr. Jennifer Y. Chen’s research program focuses on the development of novel antifibrotic therapies and biomarkers for patients with chronic liver disease.

Defining conserved mechanisms regulating stem cell behavior and how these are altered with age and in response to chronic or acute changes in metabolism.

Dissecting host mechanisms of tuberculosis (TB) pathogenesis and disease progression, defining immunological correlates of protection, and validating biomarkers and point-of-care diagnostics for TB and COVID-19

Engineering Molecular Technologies for Human Disease

Cellular and Molecular basis of nutrient-specific appetite.

Drug discovery/repurposing and disease pathogenesis mechanisms for renal, gastrointestinal, and cardiovascular diseases.

I develop computational models using brain networks, including the spread of pathology and activity in the brain.

Pathogenic Antigen-activated T cells in Autoimmune Disease